J2506 Pegfilgratim (ex Biosimilars) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Pegfilgratim (ex Biosimilars)

Brand Name:

Neulasta

Strength:

0.5mg

HCPCS:

J2506

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Immunostimulant

Minor Drug Class:

Granulocyte Colony-Stimulating Factor

Oral (Y/N):

No

FDA Approval Year:

2002

FDA Discontinuation Year:

CMS Effective Date:

Jan. 26, 2022

CMS Discontinuation Date:

Status:

In Use